Hypocaloric diet associated with the consumption of jam enriched with microencapsulated fish oil decreases insulin resistance;La dieta hipocalórica junto con mermelada enriquecida con aceite de pescado microencapsulado disminuye la resistencia a la insulina

Nutricion Hospitalaria

Volumn 29, Issue 5, 2014, Pages 1103-1108

  De Oliveira Carvalho, Anna Paula Soares ^a   Uehara, Sofia Kimi ^a   Netto, José Firmino Nogueria ^b   Rosa, Glorimar ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Fish oil; Hypocaloric diet; Insulin resistance; Metabolic syndrome; Microencapsulation

Indexed keywords

FISH OIL; GLUCOSE BLOOD LEVEL;

ADULT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG FORMULATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINISM; INSULIN RESISTANCE; LOW CALORY DIET; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; BLOOD GLUCOSE; DIET, REDUCING; DIETARY SUPPLEMENTS; DRUG COMPOUNDING; FEMALE; FISH OILS; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; SINGLE-BLIND METHOD;

EID: 84902346276     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2014.29.5.6654     Document Type: Article

References (43)

1. Guzder RN, Gatling W, Mullee MA, Byrne CD. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia 2006; 49: 49-55.
2. Gang H, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyo -rala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men in women. Arch Intern Med 2004; 164: 1066-1076.
3. Oliveira AC, Leite AB, Lima ARV, Vasconcelos SLV. Prevalên-cia de síndrome metabólica em hipertensos de município da Zo-na da Mata Alagoana. Rer Bras Cardiol. 2010; 2395: 270-276.
4. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 2007; 194: 214-221.
5. Jover A, Corbella E, Munõz A, Millán J, Pintó X, Mangas A et al. Prevalence of metabolic syndrome and its components in patients with acute coronary syndrome. Rev Esp Cardiol 2011; 64 (7): 579-586.
6. Yamazaki RK, Brito GA, Coelho I, Pequitto DC, Yamaguchi AA, Borghetti G, Schiessel DL, Kryczyk M, Machado J, Rocha RE, Aikawa J. Low fish oil intake improves insulin sensitivity, lipid profile and muscle metaboliMS on insulin resistant MSG-obese rats. Lipids Health Dis. 2011; 28: 10-66.
7. Ruff N. Distribution of α-tocopherol in fillets of turbot (Scoph-thalmusmaximus) and Atlantic halibut (Hippoglossushippoglos-sus), following dietary α-tocopheryl acetate supplementation. Aquaculture Nutrition 2004; 10:75-81.
8. Silva C, Ribeiro A, Ferreira D, Veiga F. Administração oral de peptídeos e proteínas: II. Aplicação de métodos de microencap-sulação. Rev Bra Ciênc Farm 2003; 39 (1): 1-20.
9. Matioli G, Rodriguez-Maya DB. Microencapsulação do licope-no com ciclodextrinas. Ciênc Tecnol Aliment Campinas 2003; 23: 102-105.
10. Favaro-Trindade CS, Pinho SC, Rocha GA. Revisão: Microen-capsulação de ingredientes alimentícios. Braz J Food Technol 2008; 11 (2): 103-112.
11. Higgins S, Carroll YL, O'Brien NM, Morrissey PA. Use of mi-croencapsulated fish oil as a means of increasing n-3 polyunsatu-rated fatty acid intake. J Hum Nutr Diet 1999; 12: 265-271.
12. Wallace JMW, McCabe AJ, Robson PJ, Keogh MK, Murray CA, Kelly PM et al. Bioavailability of n-3 polyunsaturated fatty acids (PUFA) in foods enriched with microencapsulated fish oil. Ann NutrMetab 2000; 44: 157-162.
13. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndorme: a global public health problem and a newdefinition. J AtherosclerThromb 2005; 12: 295-300.
14. WHO. World Health Organization. (1998). Obesity: prevention and managing the global epidemic: report of a WHO consultation on obesity. Geneva.
15. Wishnofsky M. Caloric equivalents of gained or lost weight. JAMA 1960; 173 (1): 8.
16. Institute of Medicine. Energy (IOM). In: Dietary Reference Intakes - Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Chapter 5. Washington, DC: The National Academic Press, 2002, Part 1, 51-5114.
17. Brazilian Guideline for Diagnosis and Treatment of Metabolic Syndrome. Arquivos Brasileiros de Cardiologia- Volume 84, Supplement I, April 2005.
18. Esha Research. [software]. Version 12. Salem, USA. [25 November 2010]. Retrieved from: http://www.esha.com/food-prosql.
19. Jouzel B, Pennarun AL, Prost C, Renard D, Poncelet D, De-maimay M. Encapsulation of a lipid precursor, the eicosapen-taenoic acid, to study the development of the Crassostreagigas oyster flavours. J Microencapsulation 2003; 20 (1): 35-46.
20. VI Brazilian Guidelines for Hypertension. Rev Bras Hipertens 2010; 17 (1): 1-64.
21. nded. New York, Oxford University Press, 2005.
22. Latin-American Consensus on Obesity Report. (1999). Ministry of Health.
23. Heyward VH, Stolarczyk KM. Fundamentos da composição corporal. In: Heyward VH, Stolarczyk KM. Avaliação da com-posição corporal aplicada. São Paulo: Manole; 2000. p. 2-22.
24. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
25. Matthews DR, Hosker JP, Rudenski BA, Naylor DF, Treacher DF, Turner RC. Homeostasis model assesMSent: insulin resistance and β-cell function from fasting plaMSa glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
26. Giacco R, Cuomo V, Vessby B, Uusitupa M, Hermansen K, Meyer BJ et al. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: Is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? Nutrition, Metabolism & Cardiovascular Diseases. 2007; 17: 572-580.
27. Brady LM, Lovegrove SS, Lesauvage SVM, Gower BA, Mini-hane AM, Williams CM, et al. Increased n-6 polyunsaturated fatty acids do not attenuate the effects of long-chain n-3 polyunsa -turated fatty acids on insulin sensitivity or triacylglycerol reduction in Indian Asians. Am J ClinNutr 2004; 79 (6): 983-991.
28. Simão ANC, Godeny P, Lozovoy MAB, Dichi JB, Dichi I. Efeito dos ácidos graxos n-3 no perfl glicêmico e lipídico, no estresse oxi-dativo e na capacidade antioxidante total de pacientes com síndro-me metabólica. Arq Bras Endocrinol Metab 2010; 54 (5): 463-469.
29. Jump DB Dietary polyunsaturated fatty acids and regulation of 9 gene transcription. Curr Opin Lipidol 2002; 13 (2): 155-164.
30. Almeida APF, Moura L, Chaves FR, Romaldini JH. Dislipide-mias e diabetes mellitus: fisiopatologia e tratamento. Rev Ciênc Méd Campinas 2007; 16 (4- 6): 267-277.
31. Ramel A, Martinez A, Kiely M. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Dia-betologia. 2008; 51: 1261-1268.
32. Krebs JD, Browning LM, McLean NK. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyper-insulinaemic women. Int J Obes 2006; 30: 1535-1544.
33. Waite N, Lodge J, Hart K. The impact of fish-oil supplements on insulin sensitivity. J Hum Nutr Diet 2008; 21:402-403.
34. Parra D, Bandarra NM, Kiely M, Thorsdottir I, Martínez JA. Impact of fish intake on oxidative stress when included into a mo -derate energy-restricted program to treat obesity. Eur J Nutr 2007; 46 (8): 460-467.
35. Perez-Matute P, Perez-Echarri N, Martinez JA, Marti A, Moreno-Aliaga MJ. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr 2007; 97: 389-398.
36. Pighin D, Karabatas L, Rossi A, Chicco A, Basabe JC, Lombar-do YB. Fish oil affects pancreatic fat storage, pyruvate dehydro-genase complex activity and insulin secretion in rats fed a sucrose-rich diet. J Nutr 2003; 133 (12): 4095-4101.
37. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2008; 108: 1875-1881.
38. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2008; 8: 1288-1295.
39. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S et al. Cloning of adiponectin receptors that mediate antidiabe -ticmetabolic effects. Nature. 2003; 423: 762-769.
40. Miura K, Stamler J, Nakagawa H, Elliott P, Ueshima H, Chan Q et al. Relationship of dietary linoleic acid to blood pressure. The International Study of Macro-Micronutrients and Blood Pressure Study. Hypertension 2008; 52 (2): 408-414.
41. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006; 47: 1108-1116.
42. Beyer AM, Baumbach GL, Halabi CM, Modrick ML, Lynch CM, Gerhold TD et al. Interference With PPAR Signaling Cau -ses Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling. Hypertension 2008; 51: 867-871.
43. Bahia L, Aguiar LGK, Villela NR, Bottino D, Bouskela E. O En-dotélio na Síndrome Metabólica. Arq Bras Endocrinol Metab 2006; 50: 291-303.